Antibiotic-Mediated Modulations of Outer Membrane Vesicles in Enterohemorrhagic Escherichia coli O104:H4 and O157:H7

被引：0
|
作者：
Bauwens, Andreas [1 ]
Kunsmann, Lisa [1 ]
Karch, Helge [1 ,2 ]
Mellmann, Alexander [1 ,2 ]
Bielaszewska, Martina [1 ]
机构：
[1] Univ Munster, Inst Hyg, Munster, Germany
[2] Univ Munster, Interdisciplinary Ctr Clin Res IZKF, Munster, Germany
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2017年 / 61卷 / 09期
关键词：
antibiotics; enterohemorrhagic E. coli; hemolytic uremic syndrome; outer membrane vesicles; Shiga toxins; HEMOLYTIC-UREMIC SYNDROME; SHIGA-TOXIN; PSEUDOMONAS-AERUGINOSA; STRAIN; INFECTION; OUTBREAK; GERMANY; RELEASE; RISK;
D O I：
10.1128/AAC.00937-17
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Ciprofloxacin, meropenem, fosfomycin, and polymyxin B strongly increase production of outer membrane vesicles (OMVs) in Escherichia coli O104:H4 and O157:H7. Ciprofloxacin also upregulates OMV-associated Shiga toxin 2a, the major virulence factor of these pathogens, whereas the other antibiotics increase OMV production without the toxin. These two effects might worsen the clinical outcome of infections caused by Shiga toxin-producing E. coli. Our data support the existing recommendations to avoid antibiotics for treatment of these infections.
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Intrahost milieu modulates production of outer membrane vesicles, vesicle-associated Shiga toxin 2a and cytotoxicity in Escherichia coli O157:H7 and O104:H4
    Bauwens, Andreas
    Kunsmann, Lisa
    Marejkova, Monika
    Zhang, Wenlan
    Karch, Helge
    Bielaszewska, Martina
    Mellmann, Alexander
    ENVIRONMENTAL MICROBIOLOGY REPORTS, 2017, 9 (05): : 626 - 634
  • [2] Enterohemorrhagic Escherichia coli O157:H7 infection
    Shinoda, S
    Yamamoto, S
    Tomochika, K
    Miyoshi, S
    JAPANESE JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH, 1997, 43 (01): : 1 - 14
  • [3] Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7
    Rund, Stefan A.
    Rohde, Holger
    Sonnenborn, Ulrich
    Oelschlaeger, Tobias A.
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2013, 303 (01) : 1 - 8
  • [4] INFECTIONS WITH VEROTOXIN-PRODUCING ESCHERICHIA COLI O157:H7 AND OTHER SEROTYPES, INCLUDING THE OUTBREAK STRAIN O104:H4
    Buvens, G.
    Pierard, D.
    ACTA CLINICA BELGICA, 2012, 67 (01) : 7 - 12
  • [5] Microevolution of Enterohemorrhagic Escherichia coli O104:H4 Outbreak strain
    Jenke, C.
    Bielaszewska, M.
    Zhang, W.
    Karch, H.
    Mellmann, A.
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2012, 302 : 126 - 127
  • [6] Enterohemorrhagic Escherichia coli O157:H7: case report
    Erdogan, Haluk
    Erdogan, Askin
    Levent, Belkis
    Kayali, Revasiye
    Arslan, Hande
    TURKISH JOURNAL OF PEDIATRICS, 2008, 50 (05) : 488 - 491
  • [7] Enterohemorrhagic Escherichia coli O157:H7 - An emerging pathogen
    Koutkia, P
    Mylonakis, E
    Flanigan, T
    AMERICAN FAMILY PHYSICIAN, 1997, 56 (03) : 853 - 856
  • [8] Survival of enterohemorrhagic Escherichia coli O157:H7 in water
    Wang, GD
    Doyle, MP
    JOURNAL OF FOOD PROTECTION, 1998, 61 (06) : 662 - 667
  • [9] A non-beta-lactam antibiotic inhibitor for enterohemorrhagic Escherichia coli O104:H4
    Haoqi Wang
    Arul Jayaraman
    Rani Menon
    Varun Gejji
    R. Karthikeyan
    Sandun Fernando
    Journal of Molecular Medicine, 2019, 97 : 1285 - 1297
  • [10] A non-beta-lactam antibiotic inhibitor for enterohemorrhagic Escherichia coli O104:H4
    Wang, Haoqi
    Jayaraman, Arul
    Menon, Rani
    Gejji, Varun
    Karthikeyan, R.
    Fernando, Sandun
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2019, 97 (09): : 1285 - 1297
12345